Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2018 May 1;6(2):33.
doi: 10.3390/diseases6020033.

Comparison of Brain Natriuretic Peptide Levels to Simultaneously Obtained Right Heart Hemodynamics in Stable Outpatients with Pulmonary Arterial Hypertension

Scott A Helgeson  1 , J Saadi Imam  2 , John E Moss  3 , David O Hodge  4 , Charles D Burger  5
Affiliations

Comparison of Brain Natriuretic Peptide Levels to Simultaneously Obtained Right Heart Hemodynamics in Stable Outpatients with Pulmonary Arterial Hypertension

Scott A Helgeson et al. Diseases. .

Abstract

Pulmonary arterial hypertension (PAH) is a progressive disease that requires validated biomarkers of disease severity. While PAH is defined hemodynamically by right heart catheterization (RHC), brain natriuretic peptide (BNP) is recommended by guidelines to assess disease status. Retrospectively collected data in 138 group 1 PAH patients were examined for the correlation of BNP levels to simultaneously obtained right heart catheterization (RHC). Patients were mostly Caucasian women, with functional class III symptoms, mean BNP of 406 &plusmn; 443 pg/mL, and an average right atrial pressure (RAP) of 9.9 &plusmn; 5.7 mm Hg and mean pulmonary artery pressure (mPAP) of 47.3 &plusmn; 14.7 mm Hg. Significant correlation was demonstrated between BNP and RAP (p = 0.021) and mPAP (p = 0.003). Additional correlation was seen with right heart size on echocardiography: right atrial (RAE; p = 0.04) and right ventricular enlargement (p = 0.03). An increased BNP level was an independent predictor of mortality (p < 0.0001), along with RAP (p = 0.039) and RAE (p = 0.018). Simultaneous collection of BNP at the time of RHC confirmed the correlation of BNP with right heart hemodynamics. The current results reinforce the use of BNP level as a continuous variable to assess disease severity in group 1 PAH.

Keywords: biomarkers; brain natriuretic peptide; pulmonary arterial hypertension; right heart catheterization; transthoracic echocardiogram.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Kaplan–Meier mortality curves for (A) BNP cutoff of 76 pg/mL, (B) BNP cutoff of 180 pg/mL, and (C) BNP cutoff of 240 pg/mL.
See this image and copyright information in PMC

References

    1. Austin C., Burger C., Kane G., Safford R., Blackshear J., Ung R., Shapiro B. High-risk echocardiographic features predict mortality in pulmonary arterial hypertension. Am. Heart J. 2017;189:167–176. doi: 10.1016/j.ahj.2017.04.013. - DOI - PubMed
    1. Benza R.L., Gomberg-Maitland M., Miller D.P., Frost A., Frantz R.P., Foreman A.J., McGoon M.D. The REVEAL Registry Risk Score Calculator in Patients Newly Diagnosed With Pulmonary Arterial Hypertension. Chest. 2012;141:354–362. doi: 10.1378/chest.11-0676. - DOI - PubMed
    1. Benza R.L., Miller D.P., Barst R.J., Badesch D.B., Frost A.E., McGoon M.D. An Evaluation of Long-term Survival from Time of Diagnosis in Pulmonary Arterial Hypertension from the REVEAL Registry. Chest. 2012;142:448–456. doi: 10.1378/chest.11-1460. - DOI - PubMed
    1. Benza R.L., Miller D.P., Gomberg-Maitland M., Frantz R.P., Foreman A.J., Coffey C.S., McGoon M.D. Predicting survival in pulmonary arterial hypertension: Insights from the Registry to Evaluate Early and Long-Term Pulmonary Arterial Hypertension Disease Management (REVEAL) Circulation. 2010;122:164–172. doi: 10.1161/CIRCULATIONAHA.109.898122. - DOI - PubMed
    1. Galie N., Humbert M., Vachiery J.L., Gibbs S., Lang I., Torbicki A., Hoeper M. 2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension: The Joint Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS): Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC), International Society for Heart and Lung Transplantation (ISHLT) Eur. Respir. J. 2015;46:903–975. doi: 10.1183/13993003.01032-2015. - DOI - PubMed

LinkOut - more resources